Skip to main content
Premium Trial:

Request an Annual Quote

Curidium Joins Personalized Medicine Coalition

NEW YORK (GenomeWeb News) - Curidium Medica said today that it has joined the Personalized Medicine Coalition, a US-based non-profit that aims to advance personalized medicine concepts and products.
 
The PMC is composed of pharmaceutical, biotechnology, diagnostics, and information technology companies.
 
Curidium is a UK-based developer of blood-based diagnostics for disorders of the central nervous system.
 
Earlier this week, the company said it had raised around $5 million in a share offering to fund development of PsychINDx test, a blood-based diagnostic that categorizes patients with schizophrenia/bipolar disorder into four subgroups.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.